Trial intelligence / Profile preview

Respiratory effects of tapentadol and oxycodone in healthy volunteers

2018-003515-22Phase 4Active

Sponsor
Leiden University Medical Center
Start
Oct 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of tapentadol and oxycodone in chronic pain (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Primary utility outcome. Started Oct 2018; status: active.

02

Drugs

tapentadoloxycodone
03

Conditions

chronic pain

Beyond the preview

Go deeper on 2018-003515-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-003515-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call